Description
The Department of Veteran Affairs intends to modify a sole-source contract with CareDx Inc. to perform specialized genetic blood testing on veteran patients who have undergone heart transplant surgery. The tests, Allomap and Allosure, will help determine transplant stability and avoid invasive biopsies. The contract will be for a base year with four option years. Interested parties may express their interest by 10:00 AM PDT on 7/20/26. The scope of work includes providing all necessary supplies, performing laboratory testing, and reporting results. The contractor must comply with COVID-19 safety protocols and be accredited by the Centers for Prevention and Disease Control (CDC) under CLIA.
* The contract is for genetic blood testing services
* The tests will be performed on veteran patients who have undergone heart transplant surgery
* The contract will be for a base year with four option years
* The contractor must comply with COVID-19 safety protocols
* The contractor must be accredited by the CDC under CLIA